• EPA3G a unique, patented emulsion of high purity EPA, in drinkable single sachet – containing daily dose of 3g
• Deal gives Noventure licensing rights in over 50 countries
• Agreement signed with global partner Azur Global Nutrition
Sebia enters into license agreement with Erasmus MC and Radboudumc to provide minimal residual disease test from serum samples of multiple myeloma patients
Amolyt Pharma lance une collaboration de recherche avec PeptiDream
Banook Group partners with Stefanini Group to expand support services
Vygon signs exclusive agreement with Medovate to distribute regional anaesthesia device
Vygon and Oncomfort sign international partnership for commercialization of Sedakit™, a Digital Sedation™ virtual reality solution
Vygon signe un contrat exclusif de distribution avec VGS pour la France
Minoryx Therapeutics and Sperogenix Therapeutics enter into exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and Macau
Microlight3D partners with SPS Europe to sell its Polos-µPrinter to the fast-growing maskless-lithography market
